Taken together, these data from patients with CIS or MS suggest that lower CD32b expression on naive and MZ-like B cell subsets may be associated with higher serum levels of BAFF and IgM, and EBV VCA IgM antibody seropositivity, and this phenotype is predominantly observed in females. This evidence concerns the gene FCGR2B and in situ carcinoma.